Mastercard's payment and earnings growth make it more satisfying than ever to own amid Alphabet's and Amazon's post-earnings reactions. Q3 2026 revenue rose 14% to $9.8 billion, adjusted EPS rose 21% to $5.31, and adjusted operating margin was 60.5%. Volume grew 7%, cross-border volume 11%, and $3.8 billion went to shareholders through buybacks and dividends. x.com 

Mastercard is still worth holding but offers too little upside to add after its recent run. Updated 2030 projections put the bear case at $692, 21.8% upside; the base case at $890, 56.7% upside; and the bull case at $1,198, 110.9% upside. The base case implies only about a 12% annual return, decent but not enough to buy more. x.com 

Mastercard is worth about $473 per share on 13% growth in years one to five, with a conservative case of $342 and an optimistic case of $596. The wide range depends on whether near-term growth in payment volumes holds. x.com 

Mastercard may be the only scaled, capital-light network benefiting from AI, with bloated technical debt uniquely addressable by coding tools. Nominal inflation-linked recurring revenues and hardware attach add to the case at low-teens free-cash-flow yields. While payments getting bid in a red market probably signals the rally is over, these traits could mean it is not. x.com 

Mastercard's stock should track its earnings per share over time. x.com 

Mastercard isn't really cheap for its growth, while Nvidia is cheap, and Nvidia should handily outperform Mastercard over the next three years. x.com 

Mastercard rarely goes on sale and is now a world-class compounder at one of its least demanding valuations in years. It trades at 21.8x EV/EBIT, barely above its lowest valuation since 2018 and less than half its 2021 peak multiple. x.com  x.com 

American Express's credit risk keeps its multiple below Visa's or Mastercard's, but that persistently low valuation lets management retire shares steadily. At 16x forward earnings it is not especially cheap by its own history; 28% of shares were retired over ten years. Buying here looks more like owning a steady cash-returning compounder than expecting extraordinary returns. x.com 

S&P Global, Mastercard, Visa, Moody's and Berkshire Hathaway have turned from portfolio ballast into funding shorts. These EPS compounders once pulled portfolios up alongside spicier longs, but they are never particularly cheap, Visa may rise only 4-5% on great earnings, and they can't be taken out. For most investors' horizons they are irrelevant next to momentum stocks that gap up 30% on narratives, so owning them now means being long funding shorts. That could change. x.com  x.com 

Visa's roughly 30x earnings multiple and $750 billion valuation leave less upside than other opportunities, even if it keeps executing; the best case may be another doubling over a few years. Its once-impenetrable moat may look different in five years, while its reputation as a safe compounder is already priced in. This is a relative judgment, not a prediction that Visa cannot keep rising. x.com  x.com  x.com  x.com  x.com